Inyoung Lee

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Journal of medical economics

Future oncology (London, England)

Expert opinion on drug safety

Pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Pratyusha Vadagam, Dexter Waters, Inyoung Lee, Justin Chen, Dajun Tian, Aimee M Near, Derek Lyle, Julie Vanderpoel
Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type. Journal of medical economics (2024)
Pratyusha Vadagam, Dexter Waters, Inyoung Lee, Justin Chen, Dajun Tian, Aimee M Near, Derek Lyle, Julie Vanderpoel
Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type. Journal of medical economics 27 (1) (2024)
Pratyusha Vadagam, Dexter Waters, Inyoung Lee, Justin Chen, Dajun Tian, Aimee M Near, Derek Lyle, Julie Vanderpoel
Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type. Journal of medical economics 27 (1) (2024)
Keiko Wada, Jingchuan Zhang, Inyoung Lee, Yi Wang, Aimee M Near, Vimalanand Shrikant Prabhu
Real-world utilization of lenvatinib and pembrolizumab combination therapy for the treatment of endometrial cancer in the USA. Future oncology (London, England) (2023)
Inyoung Lee, Jeremy D Jokinen, Stephanie Y Crawford, Gregory Sampang Calip, Ryan D Kilpatrick, Todd A Lee
Exploring Completeness of Adverse Event Reports as a Tool for Signal Detection in Pharmacovigilance. Therapeutic innovation & regulatory science 55 (1) (2020)
Inyoung Lee, Todd A Lee, Stephanie Y Crawford, Ryan D Kilpatrick, Gregory Sampang Calip, Jeremy D Jokinen
Impact of adverse event reports from marketing authorization holder-sponsored patient support programs on the performance of signal detection in pharmacovigilance. Expert opinion on drug safety 19 (10) (2020)
Inyoung Lee, Sruthi Adimadhyam, Edith A Nutescu, Jifang Zhou, Alemseged A Asfaw, Karen I Sweiss, Pritesh R Patel, Gregory Sampang Calip
Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study. Pharmacotherapy 39 (9) (2019)